Vertex Pharmaceuticals Incorporated shares owned by Oakmont Partners
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Oakmont Partners
from 13F filings
Historical chart of Oakmont Partners investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Oakmont Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Oakmont Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $14M | 32k | 418.01 |
| 2023-12-31 | $9.4M | 23k | 406.90 |
| 2023-09-30 | $944k | 2.7k | 347.80 |
| 2023-06-30 | $673k | 1.9k | 351.92 |
| 2023-03-31 | $502k | 1.6k | 315.08 |
| 2022-12-31 | $532k | 1.8k | 288.78 |
| 2022-09-30 | $3.1M | 12k | 250.00 |
| 2022-06-30 | $6.2M | 22k | 281.98 |
| 2022-03-31 | $595k | 2.3k | 260.85 |
| 2021-12-31 | $439k | 2.0k | 219.50 |
| 2021-09-30 | $363k | 2.0k | 181.50 |
| 2021-06-30 | $403k | 2.0k | 201.50 |
| 2021-03-31 | $430k | 2.0k | 215.00 |
| 2020-12-31 | $478k | 2.0k | 236.28 |
| 2020-09-30 | $548k | 2.0k | 271.96 |
| 2020-06-30 | $3.4M | 12k | 290.32 |
| 2020-03-31 | $476k | 2.0k | 238.00 |
| 2019-12-31 | $438k | 2.0k | 219.00 |
| 2019-09-30 | $339k | 2.0k | 169.50 |
| 2019-06-30 | $367k | 2.0k | 183.50 |
| 2019-03-31 | $368k | 2.0k | 184.00 |
| 2018-12-31 | $385k | 2.0k | 192.50 |
| 2018-09-30 | $385k | 2.0k | 192.50 |
| 2018-06-30 | $340k | 2.0k | 170.00 |
| 2018-03-31 | $326k | 2.0k | 163.00 |
| 2017-12-31 | $300k | 2.0k | 150.00 |
| 2017-09-30 | $304k | 2.0k | 152.00 |
| 2017-06-30 | $258k | 2.0k | 129.00 |
| 2017-03-31 | $219k | 2.0k | 109.50 |
| 2015-12-31 | $252k | 2.0k | 126.00 |
| 2015-09-30 | $208k | 2.0k | 104.00 |
| 2015-06-30 | $247k | 2.0k | 123.50 |
| 2015-03-31 | $236k | 2.0k | 118.00 |
| 2014-12-31 | $238k | 2.0k | 119.00 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated